Early research (Phase 1)Study completedNCT04196283
What this trial is testing
Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 30